Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 14, 2022
Patent Application Number
17165841
Date Filed
February 2, 2021
Patent Citations
...
Patent Citations Received
Patent Primary Examiner
The present disclosure relates to antisense oligonucleotides, which target SNCA mRNA (e.g., at an intron exon junction) in a cell, leading to reduced expression of SNCA protein. Reduction of SNCA protein expression is beneficial for the treatment of certain medical disorders, e.g., a neurological disorder.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
